(Q37582767)

21 August 2017

1 reference

title

How to save a life during a clinic visit for erectile dysfunction by modifying cardiovascular risk factors (English)

1 reference

21 August 2017

1 reference

1 reference

B G Schwartz

1

1 reference

21 August 2017

R A Kloner

series ordinal

2

1 reference

21 August 2017

publication date

20 August 2009

1 reference

International Journal of Impotence Research

21 August 2017

published in

1 reference

21 August 2017

volume

21

1 reference

21 August 2017

issue

6

1 reference

21 August 2017

page(s)

327-335

1 reference

Office evaluation of male sexual dysfunction

21 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2009.38

Prevention of cardiovascular disease by the early identification of erectile dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2009.38

Surveillance of cardiovascular risk factors for outpatients in different erectile dysfunction severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2009.38

A population-based, longitudinal study of erectile dysfunction and future coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2009.38

Erectile dysfunction: the earliest sign of generalized vascular disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2009.38

Relationship of penile brachial pressure index to myocardial infarction and cerebrovascular accidents in older men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2009.38

Relationship between erectile dysfunction and silent myocardial ischemia in apparently uncomplicated type 2 diabetic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2009.38

Should erectile dysfunction be considered as a marker for acute myocardial infarction? Results from a retrospective cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2009.38

Erectile dysfunction in the cardiac patient: how common and should we treat?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2009.38

Increased erythrocyte aggregation in men with coronary artery disease and erectile dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2009.38

New horizons in erectile and endothelial dysfunction research and therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2009.38

Erectile dysfunction and silent coronary artery disease: abnormal computed tomography coronary angiogram in the presence of normal exercise ECGs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2009.38

St Cyres lecture. Endothelium in control

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2009.38

Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2009.38

Erectile and endothelial dysfunction in Type II diabetes: a possible link

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2009.38

Cardiac Sexology: can we save a patient's life and his love life?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2009.38

Value and limitations of chest pain history in the evaluation of patients with suspected acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2009.38

Cardiovascular effects of the 3 phosphodiesterase-5 inhibitors approved for the treatment of erectile dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2009.38

Erectile dysfunction and heart failure: the role of phosphodiesterase type 5 inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2009.38

Cardiovascular evaluation of young patients with varicocele

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2009.38

The abdominojugular reflux sign

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2009.38

Are declining testosterone levels a major risk factor for ill-health in aging men?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2009.38

Multidetector computed tomographic angiography of the cardiovascular system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2009.38

The relationship between body fat mass and erectile dysfunction in Korean men: Hallym Aging Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2009.38

Effect of lifestyle changes on erectile dysfunction in obese men: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2009.38

Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2009.38

Intensive glycemic control in the ACCORD and ADVANCE trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2009.38

10-year follow-up of intensive glucose control in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2009.38

Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2009.38

Do lipid-lowering drugs cause erectile dysfunction? A systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2009.38

Simvastatin seems unlikely to cause impotence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2009.38

Improvement in erectile function in men with organic erectile dysfunction by correction of elevated cholesterol levels: a clinical observation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2009.38

Atorvastatin enhances sildenafil-induced vasodilation through nitric oxide-mediated mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2009.38

Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2009.38

Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2009.38

Sexual dysfunction in hypertensive men. A critical review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2009.38

Sexual activity in hypertensive men treated with valsartan or carvedilol: a crossover study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2009.38

Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2009.38

AHA/ACC Guidelines for Secondary Prevention for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2006 Update

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2009.38

Erectile dysfunction--an observable marker of diabetes mellitus? A large national epidemiological study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2009.38

7 January 2021

Erectile dysfunction and cardiovascular risk factors

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2009.38

7 January 2021

Is erectile dysfunction the "tip of the iceberg" of a systemic vascular disorder?

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2009.38

7 January 2021

Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2009.38

7 January 2021

Impaired brachial artery endothelium-dependent and -independent vasodilation in men with erectile dysfunction and no other clinical cardiovascular disease

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2009.38

7 January 2021

Prevalence of asymptomatic coronary artery disease in men with vasculogenic erectile dysfunction: a prospective angiographic study

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2009.38

7 January 2021

Endothelial dysfunction in erectile dysfunction: role of the endothelium in erectile physiology and disease

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2009.38

7 January 2021

Endothelial cell activation in men with erectile dysfunction without cardiovascular risk factors and overt vascular damage

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2009.38

7 January 2021

Erectile dysfunction and subsequent cardiovascular disease

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2009.38

7 January 2021

https://api.crossref.org/works/10.1038%2FIJIR.2009.38

1 reference

7 January 2021

The pathogenesis of atherosclerosis--an update

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2009.38

7 January 2021

Noninvasive determination of endothelium-mediated vasodilation as a screening test for coronary artery disease: pilot study to assess the predictive value in comparison with angina pectoris, exercise electrocardiography, and myocardial perfusion ima

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2009.38

7 January 2021

Smoking, smoking cessation, and risk of cardiovascular disease

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2009.38

7 January 2021

The relationship of smoking cessation to coronary heart disease and lung cancer in the Multiple Risk Factor Intervention Trial (MRFIT)

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2009.38

7 January 2021

Modifiable risk factors and erectile dysfunction: can lifestyle changes modify risk?

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2009.38

7 January 2021

Effects of intensive glucose lowering in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2009.38

7 January 2021

Erectile dysfunction and statin treatment in high cardiovascular risk patients

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2009.38

7 January 2021

Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2009.38

7 January 2021

Lowering blood pressure to prevent myocardial infarction and stroke: a new preventive strategy

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2009.38

7 January 2021

The prevalence and etiology of impotence in 101 male hypertensive outpatients

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2009.38

7 January 2021

Identifiers

DOI

10.1038/IJIR.2009.38

1 reference

21 August 2017

1 reference